Zevra Therapeutics Inc (ZVRA)
4.77
-0.05
(-1.04%)
USD |
NASDAQ |
May 16, 16:00
4.77
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Market Cap: 199.64M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 15, 2024 | 201.73M |
| May 14, 2024 | 200.90M |
| May 13, 2024 | 204.66M |
| May 10, 2024 | 201.73M |
| May 09, 2024 | 210.52M |
| May 08, 2024 | 215.96M |
| May 07, 2024 | 216.59M |
| May 06, 2024 | 215.75M |
| May 03, 2024 | 201.32M |
| May 02, 2024 | 198.79M |
| May 01, 2024 | 192.51M |
| April 30, 2024 | 191.68M |
| April 29, 2024 | 190.42M |
| April 26, 2024 | 189.16M |
| April 25, 2024 | 189.16M |
| April 24, 2024 | 190.84M |
| April 23, 2024 | 191.68M |
| April 22, 2024 | 191.26M |
| April 19, 2024 | 189.16M |
| April 18, 2024 | 188.33M |
| April 17, 2024 | 194.19M |
| April 16, 2024 | 199.63M |
| April 15, 2024 | 200.25M |
| April 12, 2024 | 200.88M |
| April 11, 2024 | 206.74M |
| Date | Value |
|---|---|
| April 10, 2024 | 205.90M |
| April 09, 2024 | 197.95M |
| April 08, 2024 | 206.74M |
| April 05, 2024 | 201.72M |
| April 04, 2024 | 205.49M |
| April 03, 2024 | 210.51M |
| April 02, 2024 | 214.07M |
| April 01, 2024 | 215.95M |
| March 28, 2024 | 242.73M |
| March 27, 2024 | 248.59M |
| March 26, 2024 | 239.38M |
| March 25, 2024 | 236.04M |
| March 22, 2024 | 241.06M |
| March 21, 2024 | 242.56M |
| March 20, 2024 | 250.87M |
| March 19, 2024 | 247.13M |
| March 18, 2024 | 247.55M |
| March 15, 2024 | 249.21M |
| March 14, 2024 | 255.44M |
| March 13, 2024 | 260.84M |
| March 12, 2024 | 259.18M |
| March 11, 2024 | 254.61M |
| March 08, 2024 | 253.36M |
| March 07, 2024 | 262.08M |
| March 06, 2024 | 259.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.387M
Minimum
Mar 18 2020
484.69M
Maximum
Jun 23 2021
158.54M
Average
170.92M
Median
Oct 02 2023
Market Cap Benchmarks
| OptiNose Inc | 146.95M |
| Perspective Therapeutics Inc | 900.92M |
| Dare Bioscience Inc | 44.06M |
| Kodiak Sciences Inc | 197.53M |
| INmune Bio Inc | 220.08M |
Market Cap Related Metrics
| PS Ratio | 6.469 |
| PEG Ratio | -0.1634 |
| Price to Book Value | 4.090 |
| Price | 4.77 |
| Earnings Yield | -28.30% |
| PEGY Ratio | -0.1634 |